Recombinant Anti-human FOLR1 Intrabody [+36 GFP]
Recombinant anti-FOLR1 intrabody in fusion with +36GFP works within cells to bind FOLR1, which is selectively overexpressed in 90% of nonmucinous ovarian carcinomas, expressed in CHO cells. FR expression is associated with tumor progression and affects cell proliferation and the intracellular expression of single-chain (sc) antibodiess (intrabody) can downmodulate membrane expression of FR in ovary cancer cells.
| Supplier | Creative Biolabs |
|---|---|
| Product # | IAB-B029(G) |
| Pricing | Inquiry |
| Host | mouse |
| Target | FOLR1 |
| Species Reactivity | human |
| Type | scFv-(+36GFP) |
| Applications | Formats of immunological tests: Western blot; Neutralization; Functional studies |
| Storage | ≥1 year at -20°C. If the reconstituted antibody cannot be used within two weeks, it should be aliquoted into smaller vials and stored at -20°C |